1. Home
  2. NUTX vs CTMX Comparison

NUTX vs CTMX Comparison

Compare NUTX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$144.53

Market Cap

912.4M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$2.97

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
CTMX
Founded
2011
2008
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
912.4M
977.1M
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
NUTX
CTMX
Price
$144.53
$2.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$252.50
$12.10
AVG Volume (30 Days)
96.2K
3.4M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
6.52
N/A
Revenue
$875,257,000.00
$76,201,000.00
Revenue This Year
$6.12
N/A
Revenue Next Year
$4.04
$7.61
P/E Ratio
$22.09
$22.58
Revenue Growth
82.36
N/A
52 Week Low
$77.21
$1.72
52 Week High
$193.07
$8.21

Technical Indicators

Market Signals
Indicator
NUTX
CTMX
Relative Strength Index (RSI) 61.94 31.88
Support Level $143.94 $2.82
Resistance Level $161.67 $3.90
Average True Range (ATR) 7.50 0.17
MACD 1.09 0.01
Stochastic Oscillator 81.44 16.76

Price Performance

Historical Comparison
NUTX
CTMX

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: